M. Brian Stuglik's most recent trade in Verastem Inc was a trade of 594 Common Stock done at an average price of $5.6 . Disclosure was reported to the exchange on June 16, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 5.65 per share. | 16 Jun 2025 | 594 | 102,326 (0%) | 0% | 5.6 | 3,356 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 13 Jun 2025 | 8,100 | 94,958 (0%) | 0% | 3.4 | 27,459 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 27,000 | 103,058 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 May 2025 | 8,333 | 102,920 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 6.95 per share. | 17 Mar 2025 | 593 | 94,587 (0%) | 0% | 6.9 | 4,121 | Common Stock |
| Verastem Inc | Stuglik M. Brian | Director | Sale of securities on an exchange or to another person at price $ 4.54 per share. | 16 Dec 2024 | 595 | 95,514 (0%) | 0% | 4.5 | 2,701 | Common Stock |
| Verastem Inc | M. Brian Stuglik | Director | Sale of securities on an exchange or to another person at price $ 4.37 per share. | 16 Dec 2024 | 334 | 95,180 (0%) | 0% | 4.4 | 1,460 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 2.79 per share. | 19 Sep 2024 | 336 | 96,109 (0%) | 0% | 2.8 | 937 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 2.80 per share. | 16 Sep 2024 | 600 | 96,445 (0%) | 0% | 2.8 | 1,680 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Jun 2024 | 27,000 | 76,058 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 12,500 | 12,500 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 8,333 | 97,380 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 3.49 per share. | 17 Jun 2024 | 593 | 89,047 (0%) | 0% | 3.5 | 2,070 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 3.21 per share. | 17 Jun 2024 | 335 | 97,045 (0%) | 0% | 3.2 | 1,075 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 3.39 per share. | 13 Jun 2024 | 9,900 | 49,058 (0%) | 0% | 3.4 | 33,528 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 10.71 per share. | 18 Mar 2024 | 537 | 89,913 (0%) | 0% | 10.7 | 5,751 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 10.38 per share. | 18 Mar 2024 | 273 | 89,640 (0%) | 0% | 10.4 | 2,834 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Mar 2024 | 11,865 | 11,865 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Brian M. Stuglik | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 7,699 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Brian M. Stuglik | Director | Sale or transfer of securities back to the company at price $ 0.00 per share. | 11 Mar 2024 | 4,166 | 0 | - | - | Stock Option (right to buy) | |
| Verastem Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 7.64 per share. | 18 Dec 2023 | 487 | 90,724 (0%) | 0% | 7.6 | 3,721 | Common Stock |
| Verastem Inc | Stuglik M. Brian | Director | Sale of securities on an exchange or to another person at price $ 7.73 per share. | 18 Dec 2023 | 274 | 90,450 (0%) | 0% | 7.7 | 2,118 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 9.92 per share. | 16 Jun 2023 | 487 | 92,238 (0%) | 0% | 9.9 | 4,831 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 10.30 per share. | 16 Jun 2023 | 275 | 91,963 (0%) | 0% | 10.3 | 2,833 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 27,000 | 58,958 (0%) | 0% | 0 | Common Stock | |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 3.46 per share. | 13 Jun 2023 | 9,900 | 31,958 (0%) | 0% | 3.5 | 34,252 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.40 per share. | 16 Mar 2023 | 6,276 | 1,116,244 (1%) | 0% | 0.4 | 2,510 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.43 per share. | 16 Mar 2023 | 3,508 | 1,112,736 (1%) | 0% | 0.4 | 1,508 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jan 2023 | 2,216,355 | 2,216,355 | - | - | Stock Option (Right to Buy) | |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.40 per share. | 16 Dec 2022 | 25,162 | 1,126,076 (1%) | 0% | 0.4 | 10,065 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 16 Dec 2022 | 3,556 | 1,122,520 (1%) | 0% | 0.4 | 1,316 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.13 per share. | 19 Sep 2022 | 3,355 | 1,151,238 (1%) | 0% | 1.1 | 3,791 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.08 per share. | 01 Aug 2022 | 5,858 | 1,154,593 (1%) | 0% | 1.1 | 6,327 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.14 per share. | 21 Jun 2022 | 3,362 | 1,160,451 (1%) | 0% | 1.1 | 3,833 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Sale of securities on an exchange or to another person at price $ 2.69 per share. | 16 Jun 2022 | 13,000 | 41,858 (0%) | 0% | 2.7 | 34,918 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 27,000 | 54,858 (0%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 May 2022 | 50,000 | 1,177,607 (1%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.03 per share. | 14 May 2022 | 13,794 | 1,163,813 (1%) | 0% | 1.0 | 14,208 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.41 per share. | 02 May 2022 | 5,857 | 1,127,607 (1%) | 0% | 1.4 | 8,258 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.27 per share. | 21 Mar 2022 | 3,507 | 1,133,464 (1%) | 0% | 1.3 | 4,454 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 1.48 per share. | 31 Jan 2022 | 5,695 | 1,136,971 (1%) | 0% | 1.5 | 8,429 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.05 per share. | 03 Jan 2022 | 26,033 | 1,142,666 (1%) | 0% | 2.1 | 53,368 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Sale of securities on an exchange or to another person at price $ 2.27 per share. | 20 Dec 2021 | 13,682 | 1,168,699 (1%) | 0% | 2.3 | 31,058 | Common Stock |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 737,000 | 737,000 | - | - | Stock Option (Right to Buy) | |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Nov 2021 | 363,000 | 1,182,381 (1%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Director, Chief Executive Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 2.59 per share. | 01 Nov 2021 | 5,839 | 819,381 (0%) | 0% | 2.6 | 15,123 | Common Stock |
| Puma Biotechnology Inc | Brian M. Stuglik | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2021 | 27,858 | 27,858 (0%) | 0% | 0 | COMMON STOCK | |
| Verastem Inc | Brian M. Stuglik | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Mar 2021 | 191,828 | 1,186,185 (1%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 611,328 | 611,328 | - | - | Stock Option (Right to Buy) | |
| Verastem Inc | Brian M. Stuglik | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Dec 2020 | 203,776 | 994,357 (1%) | 0% | 0 | Common Stock | |
| Verastem Inc | Brian M. Stuglik | Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Aug 2020 | 419,581 | 790,581 (0%) | 0% | 0 | Common Stock |